In the original CCSG grant, developmental funds were requested to support a pilot project program as a tool to stimulate inter and intra programmatic interaction and support program development. Analysis of the DLDCC pilot project program indicates that while young it has been successful. The program has generated new collaborations, extra-mural grants and publications in the desired targeted areas. Center leadership believes that an additional effective use of CCSG Developmental funds in the BCM environment is to provide operating support to develop new technology-based shared resources. Specifically, the Center would like to leverage large investments made by the Institution in three new Shared Resources including 1) Macromolecular X-Ray Crystallography, 2) Population Sciences Biorepository, and 3) Cytogenetics. The DLDCC is requesting $100,000 in CCSG funding to augment its successful and robust Pilot Project Program. The intent of the CCSG pilot project program would be to fund three - $30-40,000 per year projects targeted at funding innovative new ideas or to support strong projects that enhance strategic program development. The DLDCC is requesting a total of $210,000 to support Shared Resource with the intent of meeting specific evolving needs of the cancer center and for creating new research opportunities. The Macromolecular X-Ray Crystallography Resource builds on a recent Institutional investment in a fully equipped state-of-the art X- Ray facility. Operational support funds will enable this facility to expand services to cancer center investigators who are not trained X-ray crystallographers, and provide them with the opportunity to determine structures of cancer related macromolecules. A Population Sciences Biorepository Resource (PSB) is being set up to meet the needs of the emerging molecular epidemiologists in the Cancer Center for processing and storing biospecimens from population-based and clinical studies. The PSB is being built by start-up funds from the Cancer Center and we are requesting on-going operational support funds from the CCSG. The Cytogenetics Shared Resource is an established facility at Texas Children's Hospital (TCH) that has largely limited its services to TCH faculty and the Pediatrics Department. Operational support funds requested will expand the user base of these highly relevant cytogenetic technologies to the general membership of the cancer center. Individual abstracts for the developing SRs are included with budgets to assist the reviewer.

Public Health Relevance

Two important elements of cancer centers are access to high technology shared resources and the availability of seed funding to develop new ideas and collaborations. The DLDCC is requesting funds in these two areas to leverage its own and BCM investments. These additional resources will help Cancer Center members more effectively pursue the Center's mission.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA125123-04
Application #
8181052
Study Section
Subcommittee G - Education (NCI)
Project Start
2010-09-17
Project End
2011-06-30
Budget Start
2010-09-17
Budget End
2011-06-30
Support Year
4
Fiscal Year
2010
Total Cost
$73,674
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Zhao, Na; Cao, Jin; Xu, Longyong et al. (2018) Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer. J Clin Invest 128:1283-1299
Reznik, Ed; Luna, Augustin; Aksoy, Bülent Arman et al. (2018) A Landscape of Metabolic Variation across Tumor Types. Cell Syst 6:301-313.e3
Blue, R Eric; Koushik, Amrita; Engels, Nichlas M et al. (2018) Modulation of alternative splicing of trafficking genes by genome editing reveals functional consequences in muscle biology. Int J Biochem Cell Biol 105:134-143
Dawson, Emily P; Lanza, Denise G; Webster, Nicholas J et al. (2018) Delayed male germ cell sex-specification permits transition into embryonal carcinoma cells with features of primed pluripotency. Development 145:
Freire, Pablo R; Conneely, Orla M (2018) NR4A1 and NR4A3 restrict HSC proliferation via reciprocal regulation of C/EBP? and inflammatory signaling. Blood 131:1081-1093
Parikh, Neha; Shuck, Ryan L; Gagea, Mihai et al. (2018) Enhanced inflammation and attenuated tumor suppressor pathways are associated with oncogene-induced lung tumors in aged mice. Aging Cell 17:
Brunetti, Lorenzo; Gundry, Michael C; Kitano, Ayumi et al. (2018) Highly Efficient Gene Disruption of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9. J Vis Exp :
Newton, Jared M; Flores-Arredondo, Jose H; Suki, Sarah et al. (2018) Non-Invasive Radiofrequency Field Treatment of 4T1 Breast Tumors Induces T-cell Dependent Inflammatory Response. Sci Rep 8:3474
Bhat, Raksha R; Yadav, Puja; Sahay, Debashish et al. (2018) GPCRs profiling and identification of GPR110 as a potential new target in HER2+ breast cancer. Breast Cancer Res Treat 170:279-292
Lyon, Deborah; Lapteva, Natasha; Gee, Adrian P (2018) Absence of Replication-Competent Retrovirus in Vectors, T Cell Products, and Patient Follow-Up Samples. Mol Ther 26:6-7

Showing the most recent 10 out of 991 publications